TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Multi-Center, Open-Label, Active-Comparator Controlled Study to Evaluate the Efficacy and Safety of APL-2 in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
Brief Summary: Evaluation of the Efficacy and Safety of APL-2 in Patients with Paroxysmal Nocturnal Hemoglobinuria


Options:
A: Arm Label: Pegcetacoplan; Type: EXPERIMENTAL; Interventions: Drug: Pegcetacoplan, Drug: Soliris | Arm Label: Eculizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Pegcetacoplan, Drug: Soliris | Intervention Type: DRUG; Name: Pegcetacoplan; Assigned to Arm(s): Eculizumab, Pegcetacoplan | Intervention Type: DRUG; Name: Soliris; Assigned to Arm(s): Eculizumab, Pegcetacoplan
B: Arm Label: Saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline | Arm Label: Eculizumab; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eculizumab | Intervention Type: DRUG; Name: Eculizumab; Assigned to Arm(s): Eculizumab | Intervention Type: DRUG; Name: Saline; Assigned to Arm(s): Saline
C: Intervention Type: PROCEDURE; Name: Subfoveal Choroidal Neovascularization Removal; Assigned to Arm(s): N/A
D: Arm Label: FCFD4514S; Type: EXPERIMENTAL; Interventions: Drug: FCFD4514S | Arm Label: sham; Type: SHAM_COMPARATOR; Interventions: Drug: sham | Intervention Type: DRUG; Name: FCFD4514S; Assigned to Arm(s): FCFD4514S | Intervention Type: DRUG; Name: sham; Assigned to Arm(s): sham

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of an Online Intervention to Help LGBTQ Youth Cope With Bullying
Brief Summary: The purpose of this research study is to conduct a pilot randomized controlled trial of a game-based intervention is able to increase help-seeking-related knowledge, attitudes, and behaviors, reduce health risk factors/behaviors, and increase resiliencies among sexual and gender minority (SGM) youth. The goals of the proposed study are to: (1) Test the feasibility and acceptability of a game-based intervention to increase help-seeking-related knowledge, attitudes, and behaviors among SGM youth; and (2) Using a randomized controlled trial, test the efficacy of a game-based intervention to increase help-seeking-related knowledge, attitudes, and behaviors, reduce health risk factors/behaviors, and increase resiliencies among SGM youth.


Options:
A: Arm Label: Peer-Led Peer-Elected Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-Led Peer-Elected Intervention | Arm Label: Adult-Led Intervention; Type: OTHER; Interventions: Behavioral: Adult-Led Intervention | Arm Label: Peer-Led Non-Elected Intervention; Type: OTHER; Interventions: Behavioral: Peer-Led Non-Elected Intervention | Intervention Type: BEHAVIORAL; Name: Peer-Led Peer-Elected Intervention; Assigned to Arm(s): Peer-Led Peer-Elected Intervention | Intervention Type: BEHAVIORAL; Name: Adult-Led Intervention; Assigned to Arm(s): Adult-Led Intervention | Intervention Type: BEHAVIORAL; Name: Peer-Led Non-Elected Intervention; Assigned to Arm(s): Peer-Led Non-Elected Intervention
B: Arm Label: Project CHOICE + Getting To Outcomes; Type: EXPERIMENTAL; Interventions: Behavioral: Getting To Outcomes, Behavioral: Project CHOICE | Arm Label: Project CHOICE only; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Project CHOICE | Intervention Type: BEHAVIORAL; Name: Getting To Outcomes; Assigned to Arm(s): Project CHOICE + Getting To Outcomes | Intervention Type: BEHAVIORAL; Name: Project CHOICE; Assigned to Arm(s): Project CHOICE + Getting To Outcomes, Project CHOICE only
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Online Game | Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: LGBTQ Resources | Intervention Type: BEHAVIORAL; Name: Online Game; Assigned to Arm(s): Intervention group | Intervention Type: BEHAVIORAL; Name: LGBTQ Resources; Assigned to Arm(s): Control Group
D: Arm Label: This is Quitting; Type: EXPERIMENTAL; Interventions: Other: This is Quitting | Arm Label: Assessment only Control; Type: OTHER; Interventions: Other: Assessment only Control | Intervention Type: OTHER; Name: This is Quitting; Assigned to Arm(s): This is Quitting | Intervention Type: OTHER; Name: Assessment only Control; Assigned to Arm(s): Assessment only Control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of a Laid-back Breastfeeding Approach on Breastfeeding Initiation in Hospital Setting. A Randomized Controlled Trial
Brief Summary: The so-called biological nurturing (BN) - or laid-back breastfeeding (LB BF), a new neurobehavioral approach to breastfeeding (BF), has the potential to enhance BF initiation and to reduce breast problems (pain, fissures, etc.), while easing the newborn attachment to the breast. BN focuses on facilitating the mother to breastfeed in a relaxed, laid-back position, with her baby laying prone on her, so that the baby's body is in the largest possible contact with mother's curves. This position opens up the mother's body and promotes baby's movements through the activation of 20 primary neonatal reflexes stimulating BF. Neurophysiological studies show that, through this approach, infants instinctively know how to feed, thanks to the presence of neonatal reflexes, at the same time mothers being able to instinctively activate the same reflexes.

The main objective of this study is to assess the effectiveness of LB BF compared to standard hospital practices on the frequency of breast problems (i.e., pain, fissures, etc.) at discharge.


Options:
A: Arm Label: A&T Intervention Communes; Type: EXPERIMENTAL; Interventions: Behavioral: A&T infant and young child feeding intervention | Arm Label: Control Communes; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: A&T infant and young child feeding intervention; Assigned to Arm(s): A&T Intervention Communes
B: Arm Label: eHealth Intervention; Type: EXPERIMENTAL; Interventions: Other: eHealth Breastfeeding Co-parenting Resource | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: eHealth Breastfeeding Co-parenting Resource; Assigned to Arm(s): eHealth Intervention
C: Arm Label: Laid-back breastfeeding; Type: EXPERIMENTAL; Interventions: Other: Laid-back breastfeeding | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard care | Intervention Type: OTHER; Name: Laid-back breastfeeding; Assigned to Arm(s): Laid-back breastfeeding | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): Standard care
D: Arm Label: implementation strategy; Type: EXPERIMENTAL; Interventions: Other: implementation strategy of Breastfeeding | Arm Label: Conventional intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: implementation strategy of Breastfeeding; Assigned to Arm(s): implementation strategy

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mind/Body Interventions for Chronic Low Back and Neck Pain in Military Personnel
Brief Summary: Our primary aim is to assess the feasibility of conducting yoga research among active-duty military personnel with Chronic Low Back Pain (CLBP) and/or Chronic Neck Pain (CNP). In addition, we will evaluate the yoga intervention preferences and refine an existing yoga intervention to address those needs. The study will prepare us for a R01 funded pragmatic clinical trial of yoga for CLBP and CNP in active-duty military.


Options:
A: Arm Label: Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Education | Arm Label: Yoga; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga | Intervention Type: BEHAVIORAL; Name: Education; Assigned to Arm(s): Education | Intervention Type: BEHAVIORAL; Name: Yoga; Assigned to Arm(s): Yoga
B: Arm Label: Hatha Yoga; Type: EXPERIMENTAL; Interventions: Other: Yoga: Active Hatha | Arm Label: Restorative Yoga; Type: ACTIVE_COMPARATOR; Interventions: Other: Yoga: Restorative | Intervention Type: OTHER; Name: Yoga: Active Hatha; Assigned to Arm(s): Hatha Yoga | Intervention Type: OTHER; Name: Yoga: Restorative; Assigned to Arm(s): Restorative Yoga
C: Arm Label: Yoga Class Twice Per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class twice per week | Arm Label: Yoga Class Once per Week; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Yoga class once per week | Intervention Type: BEHAVIORAL; Name: Yoga class once per week; Assigned to Arm(s): Yoga Class Once per Week | Intervention Type: BEHAVIORAL; Name: Yoga class twice per week; Assigned to Arm(s): Yoga Class Twice Per Week
D: Arm Label: Hatha yoga; Type: EXPERIMENTAL; Interventions: Behavioral: hatha yoga | Arm Label: Health education; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: health education | Intervention Type: BEHAVIORAL; Name: hatha yoga; Assigned to Arm(s): Hatha yoga | Intervention Type: BEHAVIORAL; Name: health education; Assigned to Arm(s): Health education

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-blind, Multicenter Study Assessing Short and Long-term Efficacy, Safety, and Tolerability of Sub-cutaneous Secukinumab in Subjects of Body Weight 90 kg or Higher With Moderate to Severe Chronic Plaque-type Psoriasis
Brief Summary: The purpose of this study is to assess secukinumab high dose (every 2 weeks) vs standard dose (every 4 weeks) in heavy body weight subjects with moderate to severe plaque psoriasis.


Options:
A: Arm Label: HLX03 group; Type: EXPERIMENTAL; Interventions: Drug: HLX03 | Arm Label: adalimumab group; Type: ACTIVE_COMPARATOR; Interventions: Drug: adalimumab | Intervention Type: DRUG; Name: HLX03; Assigned to Arm(s): HLX03 group | Intervention Type: DRUG; Name: adalimumab; Assigned to Arm(s): adalimumab group
B: Arm Label: Secukinumab 300 mg every 2 weeks (Q2W); Type: EXPERIMENTAL; Interventions: Drug: secukinumab 150 mg | Arm Label: Secukinumab 300 mg every 4 weeks (Q4W); Type: ACTIVE_COMPARATOR; Interventions: Drug: secukinumab 150 mg | Arm Label: Secukinumab 300 mg every 4 weeks non-responders up-titration (Q4W NR up); Type: ACTIVE_COMPARATOR; Interventions: Drug: secukinumab 150 mg | Intervention Type: DRUG; Name: secukinumab 150 mg; Assigned to Arm(s): Secukinumab 300 mg every 2 weeks (Q2W), Secukinumab 300 mg every 4 weeks (Q4W), Secukinumab 300 mg every 4 weeks non-responders up-titration (Q4W NR up)
C: Arm Label: AIN457 150mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: secukinumab (AIN457) | Arm Label: AIN457 300mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: secukinumab (AIN457) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Etanercept; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Drug: etanercept | Arm Label: AIN457 150mg from Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: secukinumab (AIN457) | Arm Label: AIN457 300mg from Placebo; Type: EXPERIMENTAL; Interventions: Drug: Placebo, Drug: secukinumab (AIN457) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): AIN457 150mg, AIN457 150mg from Placebo, AIN457 300mg, AIN457 300mg from Placebo, Etanercept, Placebo | Intervention Type: DRUG; Name: secukinumab (AIN457); Assigned to Arm(s): AIN457 150mg, AIN457 150mg from Placebo, AIN457 300mg, AIN457 300mg from Placebo | Intervention Type: DRUG; Name: etanercept; Assigned to Arm(s): Etanercept
D: Arm Label: BMS-986165; Type: EXPERIMENTAL; Interventions: Drug: BMS-986165 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Arm Label: Active comparator; Type: ACTIVE_COMPARATOR; Interventions: Drug: Apremilast | Intervention Type: DRUG; Name: BMS-986165; Assigned to Arm(s): BMS-986165 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Apremilast; Assigned to Arm(s): Active comparator

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Randomized, Double-Blind, Placebo-Controlled, Efficacy, and Safety Study of Balovaptan in Adults With Autism Spectrum Disorder With a 2-Year Open-Label Extension
Brief Summary: This study will evaluate the efficacy, safety, and pharmacokinetics of 10 mg of oral administration balovaptan once a day (QD) compared with matching placebo in adults (18 years and older) with autism spectrum disorder (ASD).


Options:
A: Arm Label: Memantine 1; Type: EXPERIMENTAL; Interventions: Drug: Memantine Hydrochloride (HCl) | Arm Label: Memantine 2; Type: EXPERIMENTAL; Interventions: Drug: Memantine Hydrochloride (HCl) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo capsules | Intervention Type: DRUG; Name: Memantine Hydrochloride (HCl); Assigned to Arm(s): Memantine 1 | Intervention Type: DRUG; Name: Memantine Hydrochloride (HCl); Assigned to Arm(s): Memantine 2 | Intervention Type: DRUG; Name: Placebo capsules; Assigned to Arm(s): Placebo
B: Arm Label: Atomoxetine; Type: EXPERIMENTAL; Interventions: Drug: Atomoxetine | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Atomoxetine; Assigned to Arm(s): Atomoxetine | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Balovaptan; Type: EXPERIMENTAL; Interventions: Drug: Balovaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Balovaptan; Assigned to Arm(s): Balovaptan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Oxytocin nasal spray; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin nasal spray | Arm Label: Placebo nasal spray; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Oxytocin nasal spray; Assigned to Arm(s): Oxytocin nasal spray | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo nasal spray

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PeriOperative ISchemic Evaluation-3 Trial
Brief Summary: This study is a multicentre, international, randomized controlled trial of tranexamic acid (TXA) versus placebo and, using a partial factorial design, of a perioperative hypotension-avoidance versus hypertension-avoidance strategy.


Options:
A: Arm Label: tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: transamin | Arm Label: saline; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: transamin; Assigned to Arm(s): tranexamic acid
B: Arm Label: Tranexamic group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid | Arm Label: Misoprostol group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: oxytocin only group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol group | Intervention Type: DRUG; Name: Tranexamic acid; Assigned to Arm(s): Tranexamic group | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): oxytocin only group
C: Arm Label: Tranexamic Acid (TXA); Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo (0.9% normal saline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (Saline) | Arm Label: Hypotension-avoidance strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Perioperative hypotension-avoidance strategy | Arm Label: Perioperative hypertension-avoidance strategy; Type: PLACEBO_COMPARATOR; Interventions: Other: Perioperative hypertension-avoidance strategy | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic Acid (TXA) | Intervention Type: DRUG; Name: Placebo (Saline); Assigned to Arm(s): Placebo (0.9% normal saline) | Intervention Type: OTHER; Name: Perioperative hypotension-avoidance strategy; Assigned to Arm(s): Hypotension-avoidance strategy | Intervention Type: OTHER; Name: Perioperative hypertension-avoidance strategy; Assigned to Arm(s): Perioperative hypertension-avoidance strategy
D: Arm Label: TXA (1g); Type: EXPERIMENTAL; Interventions: Drug: TXA (1g) | Arm Label: Placebo (0.9% saline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (0.9% saline) | Intervention Type: DRUG; Name: TXA (1g); Assigned to Arm(s): TXA (1g) | Intervention Type: DRUG; Name: Placebo (0.9% saline); Assigned to Arm(s): Placebo (0.9% saline)

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: PeriOperative ISchemic Evaluation-3 Trial
Brief Summary: This study is a multicentre, international, randomized controlled trial of tranexamic acid (TXA) versus placebo and, using a partial factorial design, of a perioperative hypotension-avoidance versus hypertension-avoidance strategy.


Options:
A: Intervention Type: DRUG; Name: Human Thrombin; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Bovine Thrombin; Assigned to Arm(s): N/A
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Metoprolol controlled release (CR) | Arm Label: B; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Metoprolol controlled release (CR); Assigned to Arm(s): A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): B
C: Arm Label: Tranexamic Acid (TXA); Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo (0.9% normal saline); Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo (Saline) | Arm Label: Hypotension-avoidance strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Perioperative hypotension-avoidance strategy | Arm Label: Perioperative hypertension-avoidance strategy; Type: PLACEBO_COMPARATOR; Interventions: Other: Perioperative hypertension-avoidance strategy | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic Acid (TXA) | Intervention Type: DRUG; Name: Placebo (Saline); Assigned to Arm(s): Placebo (0.9% normal saline) | Intervention Type: OTHER; Name: Perioperative hypotension-avoidance strategy; Assigned to Arm(s): Hypotension-avoidance strategy | Intervention Type: OTHER; Name: Perioperative hypertension-avoidance strategy; Assigned to Arm(s): Perioperative hypertension-avoidance strategy
D: Arm Label: Tranexamic Acid; Type: EXPERIMENTAL; Interventions: Drug: tranexamic acid diluted in 100 ml of saline solution (loading dose), Drug: tranexamic acid undiluted (continous infusion) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: tranexamic acid diluted in 100 ml of saline solution (loading dose); Assigned to Arm(s): Tranexamic Acid | Intervention Type: DRUG; Name: tranexamic acid undiluted (continous infusion); Assigned to Arm(s): Tranexamic Acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Dexamethasone Twice for Pain Treatment of Total Knee Arthroplasty - A Randomized Blinded Placebo-controlled Clinical Trial
Brief Summary: Dexamethasone twice for pain treatment after total knee arthroplasty - A Placebo-controlled, randomised, parallel 3-group multicentre trial of one and two doses of dexamethasone for postoperative treatment


Options:
A: Arm Label: Dexamethasone; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Dexamethasone | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Treatment A:; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone | Arm Label: Treatment B:; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dexamethasone, Drug: Placebos | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebos | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): Treatment A:, Treatment B: | Intervention Type: DRUG; Name: Placebos; Assigned to Arm(s): Placebo, Treatment B:
C: Arm Label: Methylprednisolone; Type: EXPERIMENTAL; Interventions: Drug: Methylprednisolone 125mg | Arm Label: placebo/sodium chloride; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 2 ml | Intervention Type: DRUG; Name: Methylprednisolone 125mg; Assigned to Arm(s): Methylprednisolone | Intervention Type: DRUG; Name: Sodium Chloride 2 ml; Assigned to Arm(s): placebo/sodium chloride
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Xenon | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Sevoflurane | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: Dexamethasone | Arm Label: 4; Type: PLACEBO_COMPARATOR; Interventions: Drug: NaCl | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Drug: Ondansetron | Arm Label: 6; Type: PLACEBO_COMPARATOR; Interventions: Drug: NaCl | Intervention Type: DRUG; Name: Xenon; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sevoflurane; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Dexamethasone; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: NaCl; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: Ondansetron; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: NaCl; Assigned to Arm(s): 6

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Impact of M-health Based Intervention on Adherence to Healthy Physical Activity After Stroke. Randomized Study
Brief Summary: The aim of this study is to determine the impact of an m-health based intervention on long term adherence to a rehabilitation program for stroke survivors.


Options:
A: Arm Label: m-health stroke rehabilitation; Type: N/A; Interventions: Behavioral: Multimodal Exercise Rehabilitation Program | Intervention Type: BEHAVIORAL; Name: Multimodal Exercise Rehabilitation Program; Assigned to Arm(s): m-health stroke rehabilitation
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Other: Ballistic Strength Training | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care Physiotherapy | Intervention Type: OTHER; Name: Ballistic Strength Training; Assigned to Arm(s): Experimental | Intervention Type: OTHER; Name: Usual Care Physiotherapy; Assigned to Arm(s): Control
C: Arm Label: Arm 1; Type: OTHER; Interventions: Behavioral: Exercise | Arm Label: Arm 2; Type: OTHER; Interventions: Other: Stroke education | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: Stroke education; Assigned to Arm(s): Arm 2
D: Arm Label: AARP; Type: N/A; Interventions: N/A

Answer: A